Netflix, Oshkosh, Regeneron, Calgon Carbon, CSX Active Analyst Alerts Feb. 14th

Netflix, Inc.(NASDAQ:NFLX): Credit Suisse said Netflix’s competitive position has not changed with the recent announcements by Verizon (NYSE:VZ) and Coinstar (NASDAQ:CSTR) and’s (NASDAQ:AMZN) streaming deal with Viacom (NYSE:VIAB). The firm rates shares an Outperform and continues to believe Netflix’s competitive position remains strong.

Oshkosh Corporation(NYSE:OSK): BMO Capital believes that Oshkosh’s valuation is compelling after the stock dropped yesterday in response to the Pentagon’s budget proposal. The firm views the budget as slightly negative for Oshkosh, but the firm doesn’t expect the spending plan to have any impact on the company’s results until 2H13 at the earliest.

Regeneron Pharmaceuticals, Inc.(NASDAQ:REGN): RBC Capital raised its target on Regeneron as the firm, after conducting a survey, believes that the company’s Eylea drug will outperform expectations in the near-term and the long-term. The firm maintains an Outperform rating on the stock.

Calgon Carbon Corporation(NYSE:CCC): Brean Murray said Calgon Carbon’s preannouncement of Q4 results contained many one-time items that negatively impacted results. The firm lowered its estimates and expects the shares to decline today however they believe the underlying fundamentals and earnings power remain intact. Shares are Buy rated with a $24 price target.

CSX Corp.(NYSE:CSX): Barclays lowered CSX (NYSE:CSX) and Norfolk Southern (NYSE:NSC) estimates due to price declines in Appalachian coal The firm cut Union Pacific (NYSE:UNP) coal volumes and expects CSX to have a difficult quarter.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at